Comparison of C-reactive protein/albumin ratio and neutrophil/lymphocyte ratio with conventional biomarkers for predicting septic shock in pediatric sepsis Authors: Yunyun Zheng, Tongxin Liu, Dongmei Wei, Peilin Wang, Xiaojun Fan Published: 2026 ABSTRACT AbstractBackgroundThis study aimed to investigate the clinical utility of the C-reactive protein/albumin ratio (CAR) and the neutrophil/lymphocyte ratio (NLR) in evaluating the severity of sepsis in pediatric patients.MethodsA retrospective cohort study was conducted involving 174 pediatric patients hospitalized between June 2022 and November 2025. Sepsis and septic shock were defined according to the 2024 Phoenix criteria. Patients were stratified into a sepsis group (n = 123) and a septic shock group (n = 51). CAR and NLR were calculated from blood samples collected within 24 h of admission. A two-sided p < 0.05 was considered statistically significant. Independent associated factors for septic shock were identified using binary logistic regression analysis. Receiver operating characteristic (ROC) curves were constructed, and the area under the curve (AUC) was calculated to evaluate the diagnostic performance of CAR, NLR, and other relevant biomarkers.The study was conducted in accordance with the STROBE guidelines.ResultsUnivariate analysis revealed significantly elevated white blood cell (WBC) count, CAR, and NLR levels in the septic shock group compared to the sepsis group (all p < 0.05). Binary logistic regression analysis confirmed that elevated CAR (OR = 2.893, p < 0.001) and NLR (OR = 1.232, p < 0.001) were independent associated factors for progression to septic shock. ROC curve analysis demonstrated that a model combining CAR and NLR exhibited superior discriminative performance compared to either biomarker alone, with a higher AUC (0.802), sensitivity (74.50%), and specificity (74.80%).ConclusionCAR and NLR appear to be significant independent biomarkers for assessing severity and predicting septic shock in children with sepsis. The combination of CAR and NLR provides improved predictive accuracy compared with either marker alone, suggesting its potential utility in guiding early clinical decisions.Keywords: Septic shock, Children, C-reactive protein/albumin ratio, Neutrophil/lymphocyte ratio, Assessment value What is known C-reactive protein to albumin ratio (CAR) and neutrophil to lymphocyte ratio (NLR) are emerging biomarkers for inflammatory and infectious diseases. C-reactive protein to albumin ratio (CAR) and neutrophil to lymphocyte ratio (NLR) are emerging biomarkers for inflammatory and infectious diseases. The comparative efficacy of CAR and NLR versus traditional biomarkers in predicting septic shock in children with sepsis remains inadequately studied. The comparative efficacy of CAR and NLR versus traditional biomarkers in predicting septic shock in children with sepsis remains inadequately studied. What is new This pediatric study suggests that combining CAR and NLR predicts septic shock in children with sepsis better than either marker alone, adding to emerging evidence in this population. This pediatric study suggests that combining CAR and NLR predicts septic shock in children with sepsis better than either marker alone, adding to emerging evidence in this population. Unlike adult studies, this low-cost, age-specific panel outperforms traditional single biomarkers for early risk stratification. Unlike adult studies, this low-cost, age-specific panel outperforms traditional single biomarkers for early risk stratification. Introduction Sepsis is a life-threatening condition resulting from a dysregulated host response to infection, often culminating in multiple organ dysfunction. Globally, pediatric sepsis remains a significant public health burden, with an estimated annual incidence affecting approximately 3 million children. Without timely recognition and aggressive management, the disease can rapidly progress to its most severe manifestation—septic shock. This critical stage occurs in 5%–20% of pediatric sepsis cases and is associated with mortality rates exceeding 20%–30%. Furthermore, a substantial proportion of survivors experience long-term physical, cognitive, and psychological sequelae, imposing considerable economic and emotional strain on families and healthcare systems [1–4]. Consequently, the identification of reliable, accessible biomarkers for the early assessment of disease severity and prognosis is of paramount clinical importance. Among the array of inflammatory biomarkers, the C-reactive protein/albumin ratio (CAR) and the neutrophil/lymphocyte ratio (NLR) have emerged as promising, cost-effective parameters. These composite markers integrate information on both systemic inflammation (via CRP or neutrophils) and disease severity reflected by acute-phase reactants (via albumin, whose rapid decline in sepsis primarily results from capillary leakage and increased vascular permeability rather than nutritional status) and immune status(via lymphocytes), offering a more holistic view of the host’s inflammatory status. Previous investigations have established the robust prognostic utility of CAR and NLR across various critical illnesses [5, 6]. While existing literature predominantly supports their clinical significance in adult sepsis populations [7, 8], evidence specific to the pediatric demographic remains limited. Currently, the current consensus criteria for pediatric sepsis and septic shock is the 2024 Phoenix Criteria, which classify sepsis as suspected or confirmed infection with a Phoenix Sepsis Score (PSS) ≥ 2 points, and septic shock as sepsis with cardiovascular dysfunction [9]. Given the distinct pathophysiology and clinical presentation of sepsis in children, extrapolation from adult data may not be fully applicable. While adult studies dominate the literature on CAR and NLR, few pediatric‑specific studies have evaluated their predictive value for septic shock [10–12]. Furthermore, emerging non‑invasive biomarkers such as salivary markers have shown promise in pediatric sepsis [13, 14], offering easy repeatability and patient comfort. However, the present study focuses on readily available blood‑based ratios (CAR and NLR) that are cost‑effective and widely accessible even in resource‑limited settings. Therefore, this study aims to elucidate the diagnostic and prognostic value of CAR and NLR specifically in pediatric patients with sepsis, with a focus on their ability to predict progression to septic shock. The findings are intended to provide critical evidence to guide early risk stratification and clinical decision-making in this vulnerable population. Materials and methods Study population and design This retrospective cohort study was conducted at Hefei Second People’s Hospital. A total of 174 pediatric patients diagnosed with sepsis between June 2022 and November 2025 were enrolled (data collection completed by November 30, 2025). The age of enrolled children ranged from 0.5 to 14.0 years. Patients were stratified into two groups based on clinical progression: a sepsis group and a septic shock group. Inclusion and exclusion criteria The inclusion criteria were as follows: (1) diagnosis of sepsis or septic shock according to the 2024 International Consensus Definitions for Pediatric Sepsis and Septic Shock (Phoenix Criteria), defined as a suspected or confirmed infection with a PSS ≥ 2 points for sepsis, or sepsis accompanied by cardiovascular dysfunction for septic shock [9]; (2) no prior sepsis-specific treatment before admission (e.g., antibiotics, vasopressors, or corticosteroids) before admission; (3) availability of serum samples collected within 24 h of admission; (4) completeness of essential clinical and laboratory data. Exclusion criteria comprised: (1) preterm infants (gestational age < 37 weeks); (2) neonates hospitalized during the perinatal period; (3) presence of congenital anomalies, hematological diseases, immune system disorders, or significant coagulation abnormalities; and (4) incomplete medical records. Ethical considerations The study protocol was reviewed and approved by the Ethics Committee of Hefei Second People’s Hospital (Approval No.: 2025-Research-145, approved on December 25, 2025). The approval was granted for the retrospective analysis of previously collected clinical data (data collection had been completed on November 30, 2025). The requirement for individual informed consent was waived by the committee due to the retrospective nature of the study. Data collection Comprehensive clinical and laboratory data were retrospectively collected for all enrolled patients. Demographic information included gender and age. Laboratory parameters extracted from the first blood samples obtained after admission comprised: white blood cell count (WBC), absolute neutrophil count (ANC), absolute lymphocyte count (ALC), C-reactive protein (CRP), albumin (ALB), procalcitonin (PCT), and serum amyloid A (SAA). Based on these parameters, two key inflammatory ratios were calculated: the C-reactive protein/albumin ratio (CAR, calculated as CRP/ALB) and the neutrophil/lymphocyte ratio (NLR, calculated as ANC/ALC). The severity of organ dysfunction was assessed according to the PSS criteria. In cases where organ dysfunction extended beyond the cardiovascular system to include the kidneys, liver, or other organs, the more comprehensive Phoenix-8 scoring model was applied for relevant sub-score evaluation. Due to the retrospective design, the outcome assessors were not blinded to the laboratory results. However, patient grouping into sepsis and septic shock groups was strictly based on the Phoenix Criteria (clinical parameters only), independent of CAR and NLR values. Biological sample collection and laboratory analysis Venous blood samples (non-fasting, collected as part of routine clinical care at admission) were collected from all enrolled pediatric patients into anticoagulant-free tubes within 24 h of admission. The samples were promptly processed. A portion of each sample was centrifuged at 3000 r/min for 15 min at room temperature to separate serum. Serum levels of CRP were measured using an immunoturbidimetric assay kit. Alb concentration was determined using the bromocresol green colorimetric method. PCT was measured using a fluorescence immunochromatography assay kit, and SAA was measured using a latex‑enhanced immunoturbidimetric assay kit. A complete blood count with differential, including ANC and ALC, was performed on an automated hematology analyzer (XN-1000, Sysmex Corporation, Kobe, Japan). The CAR was calculated as CRP (mg/L) divided by Alb (g/L). The NLR was calculated as ANC (×10⁹/L) divided by ALC (×10⁹/L). All laboratory procedures were conducted in strict accordance with the manufacturer’s instructions. Statistical analysis All statistical analyses were conducted using SPSS software (version 31.0; IBM Corp., Armonk, NY, USA) and R software (version 4.3.2; R Foundation for Statistical Computing, Vienna, Austria). Normality of continuous data distribution was assessed using the Shapiro-Wilk test. Non-normally distributed measurement data were expressed as medians with interquartile ranges (IQR), and between-group comparisons were performed using the Mann-Whitney U test. Categorical variables were presented as frequencies and percentages (n, %), and intergroup differences were analyzed using the Chi-square test or Fisher’s exact test, as appropriate. No formal sample size calculation was performed; all eligible patients during the study period were included. A post-hoc power analysis indicated that the sample size (51 events) provided 80% power to detect an odds ratio of 2.5 for the primary predictors at α = 0.05. Missing data were handled by complete-case analysis, as all included patients had complete records for the variables of interest (according to inclusion criterion 4). No imputation was performed. To identify independent associated factors of septic shock, variables with a p-value < 0.05 in the univariate analysis were entered into a multivariable binary logistic regression model. Results were reported as odds ratios (OR) with 95% confidence intervals (CI). The diagnostic performance of CAR, NLR, and other relevant biomarkers for predicting septic shock was evaluated by constructing receiver operating characteristic (ROC) curves. The area under the curve (AUC) was calculated to quantify predictive accuracy. The optimal cut-off value for each biomarker was determined by maximizing the Youden index (sensitivity + specificity – 1). Positive predictive value (PPV) and negative predictive value (NPV) were calculated based on the prevalence of septic shock in the study cohort. To compare the differences in AUC values between two correlated ROC curves (e.g., CAR vs. NLR), DeLong’s test was employed. Calibration of the combined CAR and NLR model was assessed using the Hosmer‑Lemeshow goodness‑of‑fit test, with a p‑value > 0.05 indicating good calibration. Net reclassification improvement (NRI) was calculated to evaluate the incremental predictive value of the combined model over each single biomarker (CAR or NLR), and the corresponding 95% confidence intervals and p‑values were derived.A two-sided p-value < 0.05 was considered statistically significant for all analyses. The study was reported following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Results General characteristics of participants This study included a total of 123 cases in the sepsis group (male 65 (53%), female 58 (47%)) and 51 cases in the septic shock group (male 28 (55%), female 23 (45%)). The median age was 3.00 years (IQR:1.00,4.00) in the sepsis group and 1.00 year (IQR:0.70,4.00) in the septic shock group (p = 0.207). Inter-group comparisons revealed that WBC, CAR, and NLR levels in the septic shock group were significantly higher than those in the sepsis group, with all differences being statistically significant (all p < 0.05). PCT and SAA levels did not differ significantly between groups (p = 0.377 and p = 0.161 ). Detailed data are presented in Table 1. Table 1Comparison of baseline characteristics and laboratory parameters between sepsis and septic shock groupsFactorsSepsis group(n=123)Septic shock group(n=51)χ2/Z P Gender, male/female65/5828/230.0610.084aAge, years3.00(1.00,4.00)1.00(0.70,4.00)-1.2620.207bWBC, ×10⁹/L18.91(10.75,23.58)21.27(17.08,25.71)2.5280.011bPCT, ng/mL0.92(0.42,2.98)0.78(0.35,2.23)-0.8830.377bSAA, mg/L259.00(211.00,279.00)266.00(219.80,288.00)1.4000.161bCAR0.97(0.34,1.57)1.83(1.31,2.68)4.812<0.001bNLR3.45(1.50,7.86)8.47(4.04,13.38)4.730<0.001bData are presented as median (interquartile range, IQR) or number of casesWBC white blood cell, PCT procalcitonin, SAA serum amyloid A, CAR C-reactive protein/albumin ratio, NLR neutrophil/lymphocyte ratioa indicates the chi-square test, b indicates the Mann-Whitney U test Comparison of baseline characteristics and laboratory parameters between sepsis and septic shock groups Data are presented as median (interquartile range, IQR) or number of cases WBC white blood cell, PCT procalcitonin, SAA serum amyloid A, CAR C-reactive protein/albumin ratio, NLR neutrophil/lymphocyte ratio a indicates the chi-square test, b indicates the Mann-Whitney U test Independent associated factors of septic shock in children To identify independent associated factors, this study constructed a binary logistic regression model. The model designated the occurrence of septic shock as the dependent variable and included the significant indicators from univariate analysis (WBC, CAR, NLR) as independent variables. Final analysis confirmed that CAR and NLR were independent associated factors (all p < 0.001), WBC did not retain independent significance in the multivariable model (p = 0.267), with detailed data presented in Table 2. Table 2Independent associated factors of septic shock in childrenVariableβSEWaldχ2 P OR95%CIWBC0.0460.0421.2300.2671.0470.965-1.137CAR1.0620.32011.052<0.0012.8931.547-5.413NLR0.2090.06211.339<0.0011.2321.091-1.391The logistic regression model included WBC, CAR, and NLR as independent variablesWBC white blood cell, CAR C-reactive protein/albumin ratio, NLR neutrophil/lymphocyte ratio, SE standard error, OR odds ratio, CI confidence interval Independent associated factors of septic shock in children The logistic regression model included WBC, CAR, and NLR as independent variables WBC white blood cell, CAR C-reactive protein/albumin ratio, NLR neutrophil/lymphocyte ratio, SE standard error, OR odds ratio, CI confidence interval The evaluation value of serum CAR and NLR in children with septic shock ROC curve analysis was utilized to assess the discriminative ability of CAR, NLR, and their combination for identifying septic shock. The combined model was built using predicted probabilities from logistic regression including both CAR and NLR as independent variables. The combined model yielded the highest predictive accuracy, with an AUC of 0.802 (95% CI: 0.728–0.876). Notably, the AUC of the combined model was significantly greater than that of CAR alone (AUC = 0.732, 95% CI: 0.649–0.815; p = 0.031) and NLR alone (AUC = 0.728, 95% CI: 0.650–0.806; p = 0.025), as determined by DeLong’s test for two correlated ROC curves. At the optimal cut-off value (determined by the maximum Youden index of 0.493), the combined model achieved a sensitivity of 74.50%, specificity of 74.80%, PPV of 55.1%, and NPV of 87.6% for predicting septic shock (Table 3; Fig. 1). Table 3Evaluation of serum CAR and NLR in septic shockIndicatorsAUC95%CIOptimal cut-offSensitivity(%)Specificity(%)Youden indexCAR0.7320.649-0.8151.0484.3056.900.412NLR0.7280.650-0.8065.6168.6066.700.353combination0.8020.728-0.8760.2974.5074.800.493The combination of CAR and NLR shows improved predictive performance for septic shock compared to either marker alone, as indicated by a higher AUC (0.802) and Youden index (0.493)AUC area under the receiver operating characteristic curve, CAR C-reactive protein/albumin ratio, CI confidence interval, NLR neutrophil/lymphocyte ratio Evaluation of serum CAR and NLR in septic shock The combination of CAR and NLR shows improved predictive performance for septic shock compared to either marker alone, as indicated by a higher AUC (0.802) and Youden index (0.493) AUC area under the receiver operating characteristic curve, CAR C-reactive protein/albumin ratio, CI confidence interval, NLR neutrophil/lymphocyte ratio ROC curves illustrating CAR, NLR, and their combined model to predict pediatric septic shock. The blue, green, and red curves represent the ROC curves for the C-reactive protein/albumin ratio (CAR), neutrophil/lymphocyte ratio (NLR), and their combination, respectively. The diagonal gray dashed line indicates the reference line of no discriminative ability (area under the curve [AUC] = 0.5). The AUC values for CAR, NLR, and the combination were 0.732, 0.728, and 0.802, respectively. The combination of CAR and NLR demonstrated superior diagnostic performance compared to either biomarker alone Calibration of the combined model was assessed using the Hosmer‑Lemeshow goodness‑of‑fit test, which indicated good agreement between predicted and observed risks (χ² = 4.315, df = 8, p = 0.828). Furthermore, we additionally explored NRI to assess whether the combined model improved risk classification compared with each single biomarker. The point estimates suggested potential improvement with the combined model. However, given the relatively small sample size (51 events) and the absence of internal or external validation, these NRI estimates should be interpreted as exploratory. Formal assessment of reclassification performance would require validation in larger, independent cohorts. Therefore, our primary conclusions are based on the AUC comparisons, which are more robust for this sample size. Discussion Dysregulated systemic inflammatory response activation is a key feature of the progression of sepsis. Although elevated levels of inflammatory markers such as IL-6, IL-8, PCT, CRP and SAA provide some value in assessing disease severity and prognosis in pediatric sepsis, their sensitivity and specificity remain limited [15, 16]. Currently, PSS is adopted clinically as the core tool for evaluating disease severity [9]. However, its reliance on multiple parameters and complex calculations limits its utility in rapid decision-making, particularly in primary hospitals with limited resources. CRP is an acute-phase protein synthesized by the liver. Albumin is a negative acute-phase protein produced by the same organ; it maintains plasma osmotic pressure, but its rapid decline in sepsis is primarily driven by increased capillary permeability and leakage into the interstitial space rather than reduced synthesis or nutritional deficiency [17]. During infection or tissue injury, serum CRP rises sharply—sometimes over 1000-fold—whereas albumin levels drop significantly. Thus, both markers reflect the inflammatory status. However, CRP can also be elevated in various non-infectious conditions, and Alb levels are susceptible to nutritional and metabolic factors, limiting the specificity of either marker alone. The CAR combines these two indicators, offering a more stable and precise assessment of the systemic inflammatory response. Previous studies have reported an association between CAR and sepsis severity [18]. Building on this, this study further clarifies that CAR levels are significantly elevated in children with septic shock, and multivariate analysis confirms that CAR is an independent associated factor for the progression of the disease to shock. This increase in CAR directly reflects the combined effect of rising CRP and falling albumin during systemic inflammation. Neutrophils, as the primary cells in the acute inflammatory response, can phagocytose and eliminate invading pathogens. However, excessively activated neutrophils release large amounts of contents (such as enzymes and proteins), which, while clearing pathogens, also exacerbate tissue damage [19]. On the other hand, lymphocytes, responsible for immune surveillance and specific clearance, may decrease due to high consumption during persistent infection [20]. NLR reflects the imbalance between innate and specific immunity. Compared with a single indicator, NLR provides a more accurate assessment of the overall inflammatory state [21]. NLR has been used for more than two decades as a simple marker of systemic inflammation [22]. Our study not only confirms previous findings that NLR levels are positively correlated with sepsis severity [23, 24] but also clarifies that NLR is an independent associated factor for progression to septic shock. The lack of independent association for WBC in the multivariable analysis may be explained by its broad response to inflammation and infection, which overlaps with CAR and NLR. WBC is a crude marker that rises in many infectious and non-infectious conditions, whereas CAR and NLR capture more specific pathophysiological aspects: CAR integrates the acute‑phase rise of CRP with capillary leakage (albumin), and NLR reflects the balance between innate neutrophil activation and adaptive lymphocyte depletion. Thus, once CAR and NLR are accounted for, WBC does not provide additional predictive information for septic shock. ROC curve analysis revealed that combining CAR and NLR achieved significantly higher predictive accuracy for pediatric septic shock( (AUC = 0.802) than either marker alone. This indicates that integrating information from distinct pathophysiological pathways offers a more holistic clinical risk assessment. At the optimal cut‑off (Youden index 0.493), the combined model achieved a sensitivity of 74.50%, specificity of 74.80%, PPV of 55.1%, and NPV of 87.6%. This performance profile indicates that the combined CAR‑NLR marker is more useful for ruling out septic shock than for confirming it. In clinical practice, a child with values below the combined cut‑off threshold has a low likelihood (NPV 87.6%) of progressing to septic shock, providing reassurance and potentially avoiding unnecessary escalation of care. Conversely, a positive result—while warranting heightened vigilance—should be interpreted cautiously, as the moderate PPV (55.1%) means that nearly half of positive screens may not represent true septic shock. This ruling‑out capability is particularly valuable in busy emergency departments and resource‑limited settings for efficient triage of low‑risk children.The optimal cut-off values for CAR (1.04), NLR (5.61), and the combined score (0.29) provide practical thresholds for bedside risk stratification. For example, a child with sepsis and a CAR > 1.04 or NLR > 5.61 should be considered at higher risk of progressing to septic shock, prompting closer monitoring and earlier escalation of care. However, these cut-offs need prospective validation before routine clinical implementation. From a pathophysiological perspective, the limited predictive value of PCT and SAA in our cohort can be explained by several factors. PCT is primarily induced by bacterial endotoxin and inflammatory cytokines, peaking approximately 24 h after onset. In uncomplicated sepsis, PCT levels then decline, but in patients who progress to septic shock, PCT often remains persistently elevated or continues to rise due to ongoing overwhelming inflammation. This dynamic may reduce its discriminative power between sepsis and septic shock when measured at a single time point upon admission. SAA, an acute-phase protein synthesized in the liver, rises non-specifically in response to any inflammatory insult, including viral infections and tissue injury, which are common in pediatric sepsis. Its lack of specificity likely explains why SAA levels did not differ significantly between the two groups. In contrast, CAR integrates the acute-phase rise of CRP with the decline of albumin—the latter reflecting endothelial dysfunction and capillary leakage, a hallmark of septic shock progression. NLR captures the imbalance between innate neutrophil activation and adaptive lymphocyte depletion, a key feature of sepsis-induced immunosuppression. Lactate, traditionally viewed as a marker of tissue hypoperfusion, is now understood in the context of sepsis‑associated hyperlactatemia (SAHL). Rising lactate levels reflect not only hypoperfusion but also an inability to metabolize lactate due to mitochondrial dysfunction and impaired clearance, serving as a key indicator of septic shock progression. In our retrospective cohort, lactate was not systematically recorded; however, combining CAR/NLR with lactate in future prospective studies may offer complementary information on both perfusion and host immune‑inflammatory status in the setting of SAHL. Beyond single-biomarker comparisons, several studies have explored combinatorial approaches in sepsis. Li F et al. [25] reported that the procalcitonin/albumin ratio predicted sepsis severity, but its combination with CAR was not evaluated. Future research should compare different combinatorial strategies (e.g., CAR + PCT, NLR + PCT) to identify the optimal panel for resource-limited settings. To better contextualize the clinical value of CAR and NLR, a comparison with the established PSS is helpful. The PSS is a comprehensive, validated tool for assessing multiorgan dysfunction in pediatric sepsis [9]. However, its calculation requires multiple clinical and laboratory parameters, which limits rapid bedside application, particularly in resource-limited settings. In contrast, CAR and NLR are derived from routine blood tests—inexpensive, widely available, and calculable within minutes. Our combined model (AUC 0.802) offers moderate discriminative ability and is well suited as an initial screening tool to identify children at high risk of septic shock, who would then benefit from a full PSS evaluation. Future prospective studies should directly compare the incremental value of adding CAR/NLR to PSS. This finding is consistent with relevant research outcomes [26]. However, this study focuses on the pediatric population, fully considering the unique pathophysiological characteristics of sepsis in children, and validates the value of these two indicators in predicting pediatric septic shock. To our knowledge, this is one of the few pediatric studies suggesting that combining CAR and NLR may predict septic shock in children with sepsis better than either marker alone, but these findings require prospective confirmation. Unlike previous adult-based investigations, our findings account for age-specific differences in immune maturation and organ reserve, which limit direct extrapolation from adult data. Moreover, the low cost and wide availability of these two ratios make this combined panel particularly suitable for early risk stratification in resource-limited pediatric settings—a practical advantage not previously established. This study has several limitations. First, this was a retrospective cohort study, which is inherently subject to selection bias and unmeasured confounding. The sample size is constrained by the single-center design, and the relatively short follow-up period prevents observation of long-term outcomes. Second, the lack of blinding between outcome assessment and biomarker measurement may have introduced potential detection bias. Third, potential confounding factors such as underlying comorbidities and treatment variability were not adjusted for. Fourth, although the combined model showed good calibration by the Hosmer-Lemeshow test, we did not perform internal validation (e.g., bootstrapping or cross-validation), which may lead to overfitting. Fifth, the specific impact of dynamic changes in the indicators on predictive value was not explored. Future prospective studies with blinded design and multi-center enrollment are warranted to validate our findings, and further research should investigate the practical application of these indicators in guiding clinical interventions across different pediatric age groups. Conclusion In summary, this study suggests that CAR and NLR are useful predictive indicators for assessing the severity of pediatric sepsis. The combined application of these two indicators improves predictive accuracy compared with either marker alone and may provide a simple, economical assessment tool for early clinical identification of high-risk children. These findings warrant further validation in larger-scale, prospective studies. Acknowledgements Not applicable. Clinical trial number Not applicable. Abbreviations C-reactive protein/albumin ratio Neutrophil/lymphocyte ratio Receiver Operating Characteristic Area under the curve White Blood Cell Phoenix Sepsis Score Absolute neutrophil count Absolute lymphocyte count C-reactive Protein Albumin Procalcitonin Serum Amyloid A Odds Ratios Confidence Intervals Positive Predictive Value Negative Predictive Value Net Reclassification Improvement Sepsis‑associated hyperlactatemia Authors' contributions Y.Y.Z: Writing – original draft, Visualization, Formal analysis, Data curation. T.X.L: Writing – review & editing, Funding acquisition, Formal analysis, Conceptualization.D.M.W: Visualization, Software, Data curation.P.L.W: Writing – review & editing, Resources, Project administration, Conceptualization.X.J.F: Project administration. Funding No funding was received to assist with the preparation of this manuscript. Data availability The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The Ethics Committee of The Second People’s Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University approved this study. The requirement for individual informed consent was waived by the committee due to the retrospective nature of the study. The study procedures adhere to the tenets of the Declaration of Helsinki. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.